Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation

Fuminori Tokunaga1, Hiroshi Nishimasu, Ryuichiro Ishitani

  • 1Laboratory of Molecular Cell Biology, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma, Japan. ftokunaga@gunma-u.ac.jp

The EMBO Journal
|October 4, 2012
PubMed

Insights

A20 protein suppresses NF-κB activation by binding linear ubiquitin chains, revealing new insights into immune and inflammatory response regulation. This mechanism involves A20

Area of Science:

  • Molecular Biology
  • Immunology
  • Structural Biology

Background:

  • The linear ubiquitin chain assembly complex (LUBAC) activates the canonical NF-κB pathway.
  • The precise regulatory mechanisms governing LUBAC-mediated NF-κB activation are not fully understood.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of LUBAC-mediated NF-κB activation.
  • To investigate the roles of A20 and CYLD in suppressing this pathway.

Main Methods:

  • Determined crystal structures of A20's seventh zinc finger (ZF7) in complex with linear diubiquitin.
  • Utilized functional analysis to assess the impact of A20 binding on NF-κB signaling.
  • Investigated the deubiquitinase (DUB) activity of CYLD.

Main Results:

  • A20 suppresses LUBAC-mediated NF-κB activation by binding linear polyubiquitin via its ZF7 domain.
  • Crystal structures reveal A20 ZF7 simultaneously recognizes Met1-linked ubiquitins, with disease-associated mutations mapping to these sites.
  • A20 binding to linear polyubiquitin facilitates its recruitment into TNF receptor signaling complexes, inhibiting NF-κB activation.

Conclusions:

  • A20 directly inhibits LUBAC-mediated NF-κB activation through specific binding to linear ubiquitin chains.
  • CYLD also suppresses this pathway via its deubiquitinase activity.
  • These findings offer novel insights into the regulation of immune and inflammatory responses.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...